Article info

Download PDFPDF

Original research
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist

Authors

  1. Correspondence to Dr Jeffrey Schlom; schlomj{at}mail.nih.gov
View Full Text

Citation

Knudson KM, Hicks KC, Ozawa Y, et al
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist

Publication history

  • Accepted March 11, 2020
  • First published April 16, 2020.
Online issue publication 
April 16, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.